>
Zimmer Biomet Holdings Inc logo

ZBH - Zimmer Biomet Holdings Inc Share Price

$173.55 0.6  0.4%

Last Trade - 05/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £25.94bn
Enterprise Value £31.07bn
Revenue £5.10bn
Position in Universe 365th / 6846
Bullish
Bearish
Unlock ZBH Revenue
Momentum
Relative Strength (%)
1m +5.12%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.12%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
5,998 7,668 7,803 7,933 7,982 7,025 7,972 8,374 +3.2%
-15.0 -20.7 +43.1 -49.3 +141.4 -61.3 +195.3 +12.1
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2021, ZimmerBiomet Holdings Inc revenues increased 4% to $1.85B. Netincome totaled $198.1M vs. loss of $508.5M. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Net Incomereflects Goodwill impairment decrease from $612M (expense)to $0K, Selling, general and administrative decrease of 7%to $770.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ZBH
Graphical History

Revenue

ZBH Revenue Unlock ZBH Revenue

Net Income

ZBH Net Income Unlock ZBH Revenue

Normalised EPS

ZBH Normalised EPS Unlock ZBH Revenue

PE Ratio Range

ZBH PE Ratio Range Unlock ZBH Revenue

Dividend Yield Range

ZBH Dividend Yield Range Unlock ZBH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ZBH EPS Forecasts Unlock ZBH Revenue
Profile Summary

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Directors
Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated January 12, 2001
Public Since July 25, 2001
No. of Shareholders: 16,700
No. of Employees: 20,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 208,316,591
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ZBH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ZBH
Upcoming Events for ZBH
Friday 7th May, 2021 Estimate
Zimmer Biomet Holdings Inc Annual Shareholders Meeting
Tuesday 11th May, 2021
Zimmer Biomet Holdings Inc at Bank of America Global Research Healthcare Conference (Virtual)
Friday 14th May, 2021
Zimmer Biomet Holdings Inc Annual Shareholders Meeting
Monday 2nd August, 2021 Estimate
Q2 2021 Zimmer Biomet Holdings Inc Earnings Release
Thursday 4th November, 2021 Estimate
Q3 2021 Zimmer Biomet Holdings Inc Earnings Release
Frequently Asked Questions for Zimmer Biomet Holdings Inc
What is the Zimmer Biomet Holdings Inc share price?

As of 05/05/21, shares in Zimmer Biomet Holdings Inc are trading at $173.55, giving the company a market capitalisation of £25.94bn. This share price information is delayed by 15 minutes.

How has the Zimmer Biomet Holdings Inc share price performed this year?

Shares in Zimmer Biomet Holdings Inc are currently trading at $173.55 and the price has moved by 51.6% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zimmer Biomet Holdings Inc price has moved by 3.72% over the past year.

What are the analyst and broker recommendations for Zimmer Biomet Holdings Inc?

Of the analysts with advisory recommendations for Zimmer Biomet Holdings Inc, there are there are currently 14 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Zimmer Biomet Holdings Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Zimmer Biomet Holdings Inc next release its financial results?

Zimmer Biomet Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Zimmer Biomet Holdings Inc dividend yield?

The Zimmer Biomet Holdings Inc dividend yield is 0.56% based on the trailing twelve month period.

Does Zimmer Biomet Holdings Inc pay a dividend?

Last year, Zimmer Biomet Holdings Inc paid a total dividend of 0.96, and it currently has a trailing dividend yield of 0.56%. Looking ahead, Zimmer Biomet Holdings Inc has not announced an ex-dividend date yet.

When does Zimmer Biomet Holdings Inc next pay dividends?

Zimmer Biomet Holdings Inc has yet to annouce their ex-dividend date. The historic dividend yield on Zimmer Biomet Holdings Inc shares is currently 0.56%.

How do I buy Zimmer Biomet Holdings Inc shares?

To buy shares in Zimmer Biomet Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zimmer Biomet Holdings Inc?

Shares in Zimmer Biomet Holdings Inc are currently trading at $173.55, giving the company a market capitalisation of £25.94bn.

Where are Zimmer Biomet Holdings Inc shares listed? Where are Zimmer Biomet Holdings Inc shares listed?

Here are the trading details for Zimmer Biomet Holdings Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: ZBH
What kind of share is Zimmer Biomet Holdings Inc?

Based on an overall assessment of its quality, value and momentum, Zimmer Biomet Holdings Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zimmer Biomet Holdings Inc share price forecast 2021?

Shares in Zimmer Biomet Holdings Inc are currently priced at $173.55. At that level they are trading at 5.2% discount to the analyst consensus target price of 0.00.

Analysts covering Zimmer Biomet Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of 7.72 for the next financial year.

How can I tell whether the Zimmer Biomet Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zimmer Biomet Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 3.88%. At the current price of $173.55, shares in Zimmer Biomet Holdings Inc are trading at 14.8% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zimmer Biomet Holdings Inc PE Ratio?

The Zimmer Biomet Holdings Inc PE ratio based on its reported earnings over the past 12 months is 44.23. The shares are currently trading at $173.55.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Zimmer Biomet Holdings Inc?

Zimmer Biomet Holdings Inc's management team is headed by:

Larry Glasscock - NEC
Chad Phipps - SVP
Betsy Bernard - IND
Christopher Begley - LED
Gail Boudreaux - IND
Michael Farrell - IND
Sang Yi - CEX
Bryan Hanson - CHM
Ivan Tornos - COO
Suketu Upadhyay - CFO
Carrie Nichol - CAO
Keri Mattox - SVP
Ellison Humphrey - SVP
Rachel Ellingson - SVP
Who are the major shareholders of Zimmer Biomet Holdings Inc?

Here are the top five shareholders of Zimmer Biomet Holdings Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.54% (15.7m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.28% (11.0m shares)
MFS Investment Management Investment Advisor/Hedge Fund
Percentage owned: 4.62% (9.62m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 4.44% (9.24m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 3.98% (8.30m shares)
Similar to ZBH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.